1. Home
  2. FSBC vs ANNX Comparison

FSBC vs ANNX Comparison

Compare FSBC & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Star Bancorp

FSBC

Five Star Bancorp

HOLD

Current Price

$40.99

Market Cap

860.4M

Sector

Finance

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.96

Market Cap

972.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBC
ANNX
Founded
2002
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
860.4M
972.5M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FSBC
ANNX
Price
$40.99
$4.96
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$41.90
$16.50
AVG Volume (30 Days)
76.1K
1.9M
Earning Date
04-27-2026
05-11-2026
Dividend Yield
2.47%
N/A
EPS Growth
28.32
N/A
EPS
0.87
N/A
Revenue
N/A
N/A
Revenue This Year
$30.25
N/A
Revenue Next Year
$12.30
$16,320.74
P/E Ratio
$47.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.26
$1.85
52 Week High
$42.26
$7.18

Technical Indicators

Market Signals
Indicator
FSBC
ANNX
Relative Strength Index (RSI) 55.03 30.95
Support Level $39.92 $4.79
Resistance Level $41.58 $5.07
Average True Range (ATR) 1.00 0.29
MACD -0.11 -0.09
Stochastic Oscillator 51.81 3.90

Price Performance

Historical Comparison
FSBC
ANNX

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company that operates in California through its subsidiary, a state-chartered non-member bank. The company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans, and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment: Banking.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502, for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: